Fungal culture findings in cyclic vulvitis

Obstetrics and Gynecology

Volumn 96, Issue 2, 2000, Pages 301-303

  Handa, Victoria L ^a   Stice, Charles W ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; ANTIINFECTIVE AGENT; KETOCONAZOLE; POTASSIUM HYDROXIDE;

ADULT; AGED; ARTICLE; CANDIDA ALBICANS; EVALUATION; FEMALE; FUNGUS CULTURE; HUMAN; MAJOR CLINICAL STUDY; PATHOPHYSIOLOGY; PREVALENCE; PRIORITY JOURNAL; SYMPTOM; VAGINA SECRETION; VULVITIS;

ADULT; AGED; AGED, 80 AND OVER; CALIFORNIA; CANDIDA; CANDIDIASIS, VULVOVAGINAL; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; HYDROXIDES; MIDDLE AGED; PERIODICITY; POTASSIUM COMPOUNDS; PREVALENCE; RECURRENCE; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; VAGINAL SMEARS; VULVITIS;

EID: 0033948825     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0029-7844(00)00898-X     Document Type: Article

References (12)

1. Burning vulva syndrome: Report of the ISSVD task force. J Reprod Med 1984;29:457.
2. McKay M. Vulvodynia Diagnostic patterns . Dermatol Clin. 10:1992;423-433.
3. Witkin S.S., Jeremiahs J., Ledger W.J. Recurrent vaginitis as a result of sexual transmission of IgE antibodies. Am J Obstet Gynecol. 159:1988;32-36.
4. Sobel J.D. Pathophysiology of vulvovaginal candidiasis. J Reprod Med. 34:1989;572-579.
5. Procop GW, Roberts GD. Laboratory methods in basic mycology. In: Forbes BA, Sahm DF, Weissfeld AS, eds. Bailey and Scott's diagnostic microbiology. 10th ed. St. Louis: Mosby, 1998:871-962.
6. Goetsch M.F. Vulvar vestibulitis prevalence and historic features in a general gynecologic practice population . Am J Obstet Gynecol. 164:1991;1609-1616.
7. Abbott J. Clinical and microscopic diagnosis of vaginal yeast infection; a prospective analysis. Ann Emerg Med. 25:1995;587-591.
8. Eckert L.O., Hawes S.E., Stevens C.E., Koutsky L.A., Eschenbach D.A., Holmes K.K. Vulvovaginal candidiasis Clinical manifestations, risk factors, management algorithm . Obstet Gynecol. 92:1998;757-765.
9. Geiger A.M., Foxman B. Risk factors for vulvovaginal candidiasis A case-control study among university students . Epidemiology. 7:1996;182-187.
10. O'Connor M.I., Sobel J.D. Epidemiology of recurrent vulvovaginal candidiasis Identification and strain differences of Candida albicans . J Infect Dis. 154:1986;358-362.
11. Geiger A.M., Foxman B., Sobel J.D. Chronic vulvovaginal candidiasis Characteristics of women with Candida albicans, Candida glabrata, and no Candida . Genitourin Med. 71:1995;304-307.
12. Centers for Disease Control and Prevention. 1998 guidelines for treatment of sexually transmitted diseases. MMWR Morb Mortal Wkly Rep Vol. 47. Atlanta, GA: US Department of Health and Human Services, 1998.